+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celltrion - logo

Celltrion manufacturers and sells biopharmaceutical and chemical medicines. Its best known products Remsima, a monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis and adult Crohn's disease. Its antibody biosimilar pipeline includes CT-P10, CT-P17, CT-P16 and others. While its antibody biologics pipeline comprises CT-P27, CT-P26 and CT-P19. The company was founded in 2002 and is headquartered in Incheon, South Korea.

Bevacizumab Biosimilars Global Market Report 2024 - Product Thumbnail Image

Bevacizumab Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
Remicade Biosimilar Global Market Report 2024 - Product Thumbnail Image

Remicade Biosimilar Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Etanercept - Biosimilar Insight, 2024 - Product Thumbnail Image

Etanercept - Biosimilar Insight, 2024

  • Report
  • August 2024
  • 60 Pages
  • Global
From
Bevacizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Bevacizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 125 Pages
  • Global
From
Infliximab Drug Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Infliximab Drug Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Humira Drug Global Market Report 2024 - Product Thumbnail Image

Humira Drug Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Adalimumab Drugs Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 140 Pages
  • Global
From
HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Biosimilar Monoclonal Antibodies Market Report 2022-2032 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Market Report 2022-2032

  • Report
  • July 2022
  • 461 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
From
Biosimilar Monoclonal Antibodies Global Market Report 2024 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
Loading Indicator